Revolution Medicines, Inc. Warrant
Financial ratios & Valuation

Historical Multiples (2017 – 2023)

2017 2018 2019 2020 2021 2022 2023 TTM Median
Valuation Ratios
Price/Earnings ratio
-33.86-25.22-35.77-24.37-10.19-7.72-7.43N/A-24.37
Price/Sales ratio
N/A52.2734.0761.3462.3554.28280.23N/A61.34
Price/Book Value ratio
232.6310.9011.175.553.042.801.77N/A5.55
Price/Cash Flow ratio
-41.91868.98-34.36-26.34-12.45-8.55-9.25N/A-26.34
Price/Free Cash Flow ratio
-39.44-3.68K-32.66-25.59-11.92-8.16-9.05N/A-25.59
Price/Earnings Growth ratio
N/A-0.711.20-0.24-0.19-0.31-0.29N/A-0.24
Dividend Yield
N/AN/AN/AN/AN/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
N/A91.25%-83.35%-207.68%75.05%72.70%100%N/A-207.68%
Operating Profit Margin
N/A-199.99%-108.15%-257.53%-639.70%-730.01%-4207.12%N/A-257.53%
Pretax Profit Margin
N/A-207.23%-103.98%-252.49%-636.58%-704.14%-3798.71%N/A-252.49%
Net Profit Margin
N/A-207.23%-95.24%-251.63%-611.67%-702.95%-3768.28%N/A-251.63%
Effective Tax Rate
-0.33%3.21%8.40%0.34%3.91%0.16%0.80%N/A0.34%
Return on Assets
-206.45%-24.49%-21.61%-19.06%-24.35%-30.63%-21.16%N/A-19.06%
Return On Equity
-686.97%-43.23%-31.24%-22.78%-29.83%-36.29%-23.89%N/A-22.78%
Return on Capital Employed
-416.21%-28.79%-30.49%-21.27%-26.14%-34.43%-25.40%N/A-21.27%
Liquidity Ratios
Current Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/A
Quick Ratio
1.242.583.119.6231.1510.6513.06N/A9.62
Cash ratio
1.192.270.382.215.732.604.83N/A2.21
Days of Sales Outstanding
N/A132.1863.7254.2873.6348.2039.52N/A54.28
Days of Inventory outstanding
N/A1.36K0.00N/A-633.170.00N/AN/AN/A
Operating Cycle
N/A1.49K63.7254.28-559.5448.20N/AN/A54.28
Days of Payables Outstanding
1.03K1.08K45.3434.79699.78805.37N/AN/A34.79
Cash Conversion Cycle
N/A413.8018.3719.48-1.25K-757.16N/AN/A19.48
Debt Ratios
Debt Ratio
N/AN/AN/AN/A0.000.000.00N/AN/A
Debt Equity Ratio
N/AN/AN/AN/A0.010.000.00N/AN/A
Long-term Debt to Capitalization
N/AN/AN/AN/AN/AN/AN/AN/AN/A
Total Debt to Capitalization
N/AN/AN/AN/A0.010.000.00N/AN/A
Interest Coverage Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/A
Cash Flow to Debt Ratio
N/AN/AN/AN/A-23.68-33.13-47.57N/AN/A
Company Equity Multiplier
3.321.761.441.191.221.181.12N/A1.19
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
N/A0.06-0.99-2.32-5.00-6.34-30.27N/A-2.32
Free Cash Flow / Operating Cash Flow Ratio
1.06-0.231.051.021.041.041.02N/A1.02
Cash Flow Coverage Ratio
N/AN/AN/AN/A-23.68-33.13-47.57N/AN/A
Short Term Coverage Ratio
N/AN/AN/AN/A-23.68-33.13-47.57N/AN/A
Dividend Payout Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/A